@article{af69d19689204ce297078f7e56b423ad,
title = "Nuclear Medicine Beyond VISION",
author = "Fendler, \{Wolfgang P.\} and Ken Herrmann and Matthias Eiber",
note = "Funding Information: Wolfgang Fendler is a consultant for Endocyte and BTG, and he received fees from RadioMedix, Bayer, and Parexel outside the submitted work. Ken Herrmann receives personal fees from Bayer SIRTEX, Adacap, Curium, Endocyte, IPSEN, Siemens Healthineers, GE Healthcare, Amgen, Novartis, and ymabs; personal fees and other from Sofie Biosciences; nonfinancial support from ABX; and grants and personal fees from BTG, outside the submitted work. Matthias Eiber has an advisory role with Blue Earth Diagnostics, Point Biopharma, Telix, and Janssen and a patent application for rhPSMA. No other potential conflict of interest relevant to this article was reported.",
year = "2021",
month = jul,
day = "1",
doi = "10.2967/jnumed.121.262441",
language = "English",
volume = "62",
pages = "916--917",
journal = "Journal of Nuclear Medicine",
issn = "0161-5505",
publisher = "Society of Nuclear Medicine Inc.",
number = "7",
}